European Association for the Study of Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol2012; 57: 167–85. http://dx.doi.org/10.1016/j.jhep.2012.02.010
2.
PanCQ, ZhangJX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci2005; 2: 36–40.
PanCQ, HuKQ, TsaiN. Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients. Antivir Ther2013; 18: 841–52. http://dx.doi.org/10.3851/IMP2481
7.
WisemanE, FraserM, HoldenS. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust2009; 190: 489–92.
8.
ZhangH, PanCQ, PangQ. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology2014; 60: 468–76.
9.
ZouH, ChenY, DuanZ. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat2012; 19: e18–25. http://dx.doi.org/10.1111/j.1365-2893.2011.01492.x
10.
XuWM, CuiYT, WangL. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat2009; 16: 94–103. http://dx.doi.org/10.1111/j.1365-2893.2008.01056.x
11.
PanCQ, ZouH-B, ChenY. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol2013; 11: 1349–55. http://dx.doi.org/10.1016/j.cgh.2013.04.026
12.
PanCQ, HanGR, JiangHX. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol2012; 10: 520–6. http://dx.doi.org/10.1016/j.cgh.2012.01.019
13.
Del CanhoR, GrosheidePM, SchalmSW. Failure of neonatal hepatitis B vaccination: the role of HBV DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol1994; 20: 483–6.
